DNLI
Price
$20.73
Change
-$0.86 (-3.98%)
Updated
Feb 21 closing price
Capitalization
2.98B
9 days until earnings call
PYXS
Price
$1.28
Change
-$0.08 (-5.88%)
Updated
Feb 21 closing price
Capitalization
76.12M
26 days until earnings call
Ad is loading...

DNLI vs PYXS

Header iconDNLI vs PYXS Comparison
Open Charts DNLI vs PYXSBanner chart's image
Denali Therapeutics
Price$20.73
Change-$0.86 (-3.98%)
Volume$849.19K
Capitalization2.98B
Pyxis Oncology
Price$1.28
Change-$0.08 (-5.88%)
Volume$635.02K
Capitalization76.12M
DNLI vs PYXS Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. PYXS commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and PYXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (DNLI: $21.59 vs. PYXS: $1.36)
Brand notoriety: DNLI and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 79% vs. PYXS: 53%
Market capitalization -- DNLI: $2.98B vs. PYXS: $76.12M
DNLI [@Biotechnology] is valued at $2.98B. PYXS’s [@Biotechnology] market capitalization is $76.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • PYXS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +1.31% price change this week, while PYXS (@Biotechnology) price change was +4.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

PYXS is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.98B) has a higher market cap than PYXS($76.1M). DNLI YTD gains are higher at: 5.937 vs. PYXS (-12.821). PYXS has higher annual earnings (EBITDA): -64.04M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. PYXS (145M). PYXS has less debt than DNLI: PYXS (20.5M) vs DNLI (52.5M). PYXS has higher revenues than DNLI: PYXS (16.1M) vs DNLI (0).
DNLIPYXSDNLI / PYXS
Capitalization2.98B76.1M3,920%
EBITDA-496.05M-64.04M775%
Gain YTD5.937-12.821-46%
P/E RatioN/AN/A-
Revenue016.1M-
Total Cash837M145M577%
Total Debt52.5M20.5M256%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIPYXS
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YPF38.391.28
+3.45%
YPF Sociedad Anonima
PM151.571.77
+1.18%
Philip Morris International
IMAB0.97N/A
-0.34%
I-MAB
RXST30.33-0.40
-1.30%
RxSight
SVRA2.69-0.11
-3.93%
Savara

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-2.88%
BEAM - DNLI
59%
Loosely correlated
-2.79%
LGND - DNLI
53%
Loosely correlated
+0.01%
ACLX - DNLI
51%
Loosely correlated
+3.67%
RCKT - DNLI
50%
Loosely correlated
-0.46%
VCYT - DNLI
50%
Loosely correlated
-2.52%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+0.74%
KURA - PYXS
59%
Loosely correlated
-1.69%
CTMX - PYXS
39%
Loosely correlated
+1.91%
BEAM - PYXS
38%
Loosely correlated
-2.79%
DNLI - PYXS
38%
Loosely correlated
-2.88%
ABOS - PYXS
36%
Loosely correlated
-1.43%
More